e-learning
resources
Berlin 2001
Monday 24.09.2001
Assessment and monitoring of inflammation in COPD and asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Predictive value of sputum eosinophilia for the rapid decline of FEV1 after a three-day withdrawal of therapy in asthmatic subjects
I. Conti, A. Carletti, L. Scuotri, M. Tonelli, M. L. Bartoli, B. Vagaggini, E. Bacci, P. L. Paggiaro (Pisa, Italy)
Source:
Annual Congress 2001 - Assessment and monitoring of inflammation in COPD and asthma
Session:
Assessment and monitoring of inflammation in COPD and asthma
Session type:
Poster Discussion
Number:
2226
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Conti, A. Carletti, L. Scuotri, M. Tonelli, M. L. Bartoli, B. Vagaggini, E. Bacci, P. L. Paggiaro (Pisa, Italy). Predictive value of sputum eosinophilia for the rapid decline of FEV1 after a three-day withdrawal of therapy in asthmatic subjects. Eur Respir J 2001; 16: Suppl. 31, 2226
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Baseline FEV
1
and sputum neutrophils and macrophages predict the decrease in FEV
1
after inhaled corticosteroid withdrawal in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 306s
Year: 2004
Sputum eosinophilia and FEV1 decline in occupational asthma
Source: Annual Congress 2008 - Asthma and inhalation injuries at work
Year: 2008
Reducing the decline of FEV
1
after a 4-year therapy with montelukast in patients with bronchial asthma
Source: Annual Congress 2008 - Recent advances in the pathogenesis and treatment of asthma and COPD
Year: 2008
Immediate bronchodilation response in FEV1 as a diagnostic criterion of adult asthma
Source: International Congress 2018 – Clinical markers of asthma
Year: 2018
sGaw as an alternative for FEV1 in the measurement of airway responsiveness to methacholine in patients experiencing chronic cough
Source: Annual Congress 2011 - Lung function today and tomorrow I
Year: 2011
Changes in lung function and airway eosinophilia after reduction of ICS treatment and recurrence of asthmatic symptoms
Source: Eur Respir J 2003; 22: Suppl. 45, 547s
Year: 2003
FEV1 decline and eosinophilia in occupational asthma
Source: Annual Congress 2011 - The work environment in the clinic
Year: 2011
Immediate bronchodilator response in FEV
1
as a diagnostic criterion for adult asthma
Source: Eur Respir J, 53 (2) 1800904; 10.1183/13993003.00904-2018
Year: 2019
Sputum bacteriology in acute COPD exacerbations: correlation with FEV
1
deterioration
Source: Eur Respir J 2001; 18: Suppl. 33, 189s
Year: 2001
A treatment regime based on induced sputum eosinophilia does not result in a reduction in exacerbations in refractory severe asthmatics
Source: Annual Congress 2008 - Severe asthma: a heterogeneous clinical entity
Year: 2008
Regular follow-up in severe asthma may reduce the rate of exacerbations and the FEV1 decline
Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases
Year: 2011
Patterns of bronchodilator reversibility of FEV1 in asthma and COPD patients
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012
Should bronchodilator response be assessed in all asthmatic children with normal baseline spirometry?
Source: International Congress 2018 – New ideas about respiratory and sleep physiology in children
Year: 2018
Longitudinal variability of pulmonary function and sputum eosinophilia in severe refractory asthmatics
Source: Eur Respir J 2003; 22: Suppl. 45, 479s
Year: 2003
Assessment and evaluation of symptomatic steroid-naive asthmatics without sputum eosinophilia and their response to inhaled corticosteroids
Source: Eur Respir J 2002; 20: 1364-1369
Year: 2002
Spirometric changes in bronchodilation tests as predictors of asthma diagnosis and treatment response in patients with FEV1 =80% predicted
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021
Does positive bronchodilator reversibility testing predict positive bronchoprovocative methacholine challenge testing in suspected asthma patients
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016
Predictors of sputum eosinophilia in severe asthma
Source: Virtual Congress 2020 – Clinical parameters in severe asthma
Year: 2020
The predictive values of bronchodilator reversibility indicators in asthmatic patients with non-obstructive patterns of spirometry
Source: International Congress 2019 – Respiratory function assessment in disease
Year: 2019
Correlation between ECP in induced sputum and asthma symptoms in children treated with budesonide
Source: Eur Respir J 2001; 18: Suppl. 33, 450s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept